LONG‐TERM RESULTS FROM EPCORE NHL‐2: FIXED‐DURATION EPCORITAMAB + R‐CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA WITH HIGH‐RISK FEATURES | Publicación